Katherine Beebe Devarney
NIH Rank #1530
- Program Leader
- Top 10% Funded
- Early Career
NIH Funding · FY2024
Total Funding
$4.1M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#1,530
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $4.1M across 1 grant · National rank #1530.
Top grants by award amount
Katherine Beebe Devarney's NIH grant portfolio, ranked by award amount.
- 1U01DA059994-01U01Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).$4.1Maward amount
Affiliation
Institutions that have administered grants for Katherine Beebe Devarney.
Affiliated with Biocorrx Pharmaceuticals Inc (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardBiocorrx Pharmaceuticals Inc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1530
- 2024Entered Top 25% NationallyRanked #1530
- 2024Entered Top 10% NationallyRanked #1530
Explore further
Find collaborators for Katherine Beebe Devarney
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Biocorrx Pharmaceuticals Inc
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →